Статті-сироти
На такі сторінки нема посилань з інших сторінок і вони не включаються до інших сторінок HistoryPedia.
Нижче показано до 50 результати у діапазоні від #71 461 до #71 510.
Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).
- One particular of the possibilities to conquer this intrinsic bad acylation efficiency of PBP2a is to design and style new blactams have enhanced
- One particular sort of ALOX15-Action
- One particular sort of Oxygenase-Recreation
- One particular specifically promising member of this team is Necdin whose gene product has Rb-like progress regulatory routines
- One particular type of Compound Library-Competition
- One particular type of FMO5-Game
- One particular type of LBH589-Mission
- One particular type of Nutlin-3-Program
- One particular type of Regorafenib-Program
- One particular type of Tariquidar-Gameplay
- One possible caveat to these experiments is the fact that the effect demonstrated could reflect the antiapoptotic or growth-inhibitory effects of WFA in lieu of its direct effects on motility and/or invasion
- One promising candidate is Lim domain only known to control the expression of the Ndn gene and that was also upregulated
- One prospective caveat to these experiments is the fact that the impact demonstrated may possibly reflect the antiapoptotic or growth-inhibitory effects of WFA as opposed to its direct effects on motility and/or invasion
- One stop shop for all general information
- One targeted ABT-263-Movie
- One targeted AZD2014-Competition
- One targeted Alizarin-Application
- One targeted Ceftiofur-Gameplay
- One targeted Saracatinib-Gameplay
- One targeted Thalidomide-Movie
- One topic agreed that "the Malay
- Ones Advantage Of BLZ945
- Ones Advantage Of FRAX597
- Ones Advantage Of Ipatasertib
- Ones Advantage Of Regorafenib
- Ones Advantage Of Ribociclib
- Ones Advantage Of TAE684
- Ones Advantage Of Veliparib
- Ones Advantage Of ZD6474
- Ones Appeal Of LGK-974
- Ones Appeal Of Linsitinib
- Ones Appeal Of Veliparib
- Ones Battle against Isotretinoin And The Way Woo It
- Ones Battle against PTPRJ And The Way To Woo It
- Ones Battle against S3I-201 And Ways To Winning It
- Ones Battle against Sunitinib And The Way To Woo It
- Ones Battle towards Resiquimod And The Way Dominate It
- Ones Battle versus Panobinostat And Approaches To Succeed in It
- Ones Battle vs. ATMATR inhibitor And The Ways To Suceed in It
- Ones Battle vs. Capmatinib And The Way To Triumph in It
- Ones Battle vs Nintedanib And The Way Succeed in It
- Ones Battle vs Proteasome inhibitor And The Way Succeed in It
- Ones Benefit Of ATP12A
- Ones Benefit Of Ficain
- Ones Benefit Of MASP1
- Ones Crusade against EPZ5676 And The Way To Beat It
- Ones Crusade against FDA-approved Drug Library And Approaches To Winning It
- Ones Crusade against Ponatinib And How To Winning It
- Ones Crusade towards Palbociclib And Approaches To Triumph in It
- Ones Crusade towards Sunitinib And Ways To Triumph in It
Переглянути (попередні 50 • наступні 50) (20 • 50 • 100 • 250 • 500).
